ERBB4 and pancreatic ductal adenocarcinoma: The BTC‐EGFR‐ERBB4 pathway in pancreatic ductal adenocarcinoma has been well established by several groups and a BTC knock out can partially rescue the cancer progression (Hedegger et al, 2020).